Alfei Silvana, Caviglia Debora, Piatti Gabriella, Zuccari Guendalina, Schito Anna Maria
Department of Pharmacy, University of Genoa, Viale Cembrano, 16148 Genoa, Italy.
Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Viale Benedetto XV-6, 16132 Genoa, Italy.
Nanomaterials (Basel). 2022 Aug 10;12(16):2743. doi: 10.3390/nano12162743.
Untreatable infections, growing healthcare costs, and increasing human mortality due to the rising resistance of bacteria to most of the available antibiotics are global phenomena that urgently require the discovery of new and effective antimicrobial agents. Cationic macromolecules, acting as membrane disruptors, are widely studied, and several compounds, including two styrene-based copolymers developed by us (P5 and P7), have proved to possess potent broad-spectrum antibacterial effects, regardless of the resistance profiles of the bacteria. Here, we first reported the synthesis and physicochemical characterization of new cationic nanoparticles (NPs) ( and ), obtained by polymerizing the monomers 4-ammoniummethylstyrene (4-AMSTY) and 4-ammoniumethylstyrene (4-AESTY) hydrochlorides, whose structures were designed using the cationic monomers of P5 and P7 as template compounds. The antibacterial activity of and was assessed against several Gram-positive and Gram-negative multi-drug resistant (MDR) pathogens, observing potent antibacterial effects for both (MICs = 0.1-0.8 µM) and (MICs = 0.35-2.8 µM) against most of the tested isolates. Additionally, time-killing studies carried out with and on different strains of the most clinically relevant MDR species demonstrated that they kill pathogens rapidly. Due to their interesting physicochemical characteristics, which could enable their mutual formulation as hydrogels, and could represent promising ingredients for the development of novel antibacterial dosage forms for topical applications, capable of overcoming severe infections sustained by bacteria resistant to the presently available antibiotics.
由于细菌对大多数现有抗生素的耐药性不断增强,导致无法治疗的感染、医疗成本不断增加以及人类死亡率上升,这些都是全球性现象,迫切需要发现新的有效抗菌剂。作为膜破坏剂的阳离子大分子受到广泛研究,包括我们开发的两种苯乙烯基共聚物(P5和P7)在内的几种化合物已被证明具有强大的广谱抗菌作用,无论细菌的耐药情况如何。在此,我们首次报道了通过聚合单体4-氯化铵甲基苯乙烯(4-AMSTY)和4-氯化铵乙基苯乙烯(4-AESTY)盐酸盐获得的新型阳离子纳米颗粒(NPs)( 和 )的合成及物理化学表征,其结构是以P5和P7的阳离子单体为模板化合物设计的。评估了 和 对几种革兰氏阳性和革兰氏阴性多药耐药(MDR)病原体的抗菌活性,观察到 (MICs = 0.1 - 0.8 µM)和 (MICs = 0.35 - 2.8 µM)对大多数测试菌株均有强大的抗菌作用。此外,用 和 对最具临床相关性的MDR菌种的不同菌株进行的杀菌研究表明,它们能迅速杀死病原体。由于其有趣的物理化学特性,这可能使它们能够相互配制成水凝胶, 和 可能是开发用于局部应用的新型抗菌剂型的有前景的成分,能够克服由对现有抗生素耐药的细菌引起的严重感染。